We previously reported a 39-year-old man who presented with pulmonary and cerebral Cryptococcus gattii (genotype VGIIa) infection and was successfully treated with liposomal amphotericin B and flucytosine induction therapy. Following induction therapy, oral fluconazole treatment was initiated as consolidation therapy. However, the patient complained of progressively worsening headache, presenting an elevated cerebrospinal fluid (CSF) cell count. The minimum inhibitory concentrations of the CSF isolate were 8 and 0.12 μg/mL for fluconazole and voriconazole, respectively. The oral administration of voriconazole for more than 18 months alleviated his symptoms. Voriconazole might be useful for controlling refractory cases of C. gattii infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666213PMC
http://dx.doi.org/10.2169/internalmedicine.5866-20DOI Listing

Publication Analysis

Top Keywords

cryptococcus gattii
8
gattii infection
8
induction therapy
8
treatment cryptococcus
4
voriconazole
4
infection voriconazole
4
voriconazole reported
4
reported 39-year-old
4
39-year-old man
4
man presented
4

Similar Publications

Divergent paths: gene evolution in Cryptococcus and implications for pathogenicity.

Curr Med Mycol

April 2024

Department of Biotechnology, College of Science, University of Anbar, Ramadi, Anbar, Iraq.

Background And Purpose: and are highly virulent species that cause diseases, such as meningoencephalitis and pulmonary infections. The gene predominantly determines the virulence of the pathogenic species. This study aimed to examine in both pathogenic and non-pathogenic species.

View Article and Find Full Text PDF

Cryptococcosis is a lethal mycosis instigated by the pathogenic species Cryptococcus neoformans and Cryptococcus gattii, primarily affects the lungs, manifesting as pneumonia, and the brain, where it presents as meningitis. Mortality rate could reach 100% if infections remain untreated in cryptococcal meningitis. Treatment options for cryptococcosis are limited and and there are no licensed vaccines clinically available to treat or prevent cryptococcosis.

View Article and Find Full Text PDF

Effect of insertion of intein to Cryptococcus amylolentus, a nonpathogenic fungus closely related to causative agents of cryptococcosis.

Microb Pathog

December 2024

Department of Pharmacology and Toxicology, R Ken Coit College of Pharmacy, 1703 E Mabel St, Tucson, AZ, 85721-0207, USA; The BIO5 Institute, The University of Arizona, Tucson, AZ, 85721, USA; Biological Chemistry Program, Department of Chemistry and Biochemistry, College of Science & College of Medicine, The University of Arizona, Tucson, AZ, 85721, USA; Department of Molecular & Cellular Biology, College of Science, The University of Arizona, Tucson, AZ, 85721, USA. Electronic address:

Inteins are mobile elements within a host protein, with flanking exteins. Autocleavage of intein results in the fusion of exteins, leading to activation of protein. The presence of intein is species dependent.

View Article and Find Full Text PDF

Cryptococcus neoformans/gattii and Histoplasma capsulatum var. capsulatum may present atypical histopathological features inducing diagnostic errors. We aimed to estimate the frequency of these atypical features on formalin-fixed tissue samples (FT) and to assess the relevance of an integrated histomolecular diagnosis using specific Histoplasma capsulatum PCR and panfungal PCR followed by Sanger sequencing and/or targeted-massive parallel sequencing (MPS).

View Article and Find Full Text PDF

Unlabelled: Commercial antifungal susceptibility tests were available for clinical yeast isolates. However, the updated Sensititre YeastOne (SYO) version YO10C excluded species for susceptibility testing. Uncorrelation of antifungal susceptibility patterns by SYO and therapeutic outcomes had been recently reported.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!